Prescribing of high-cost targeted therapies in England is diverging by region
There is marked and growing regional variation in the prescribing of targeted therapies across England. Further research should explore the reasons for this divergence to ensure equitable access to these highly effective treatments for patients with chronic inflammatory disorders, irrespective of geography.
Authors
- Sinéad Langan (ORCID: https://orcid.org/0000-0002-7022-7441)
- James Benjamin Galloway (ORCID: https://orcid.org/0000-0002-1230-2781)
- Julian Matthewman (ORCID: https://orcid.org/0000-0003-3291-2381)
- Mark Russell (ORCID: https://orcid.org/0000-0001-8171-7772)
- Reecha Sofat
Institutions
- University of Liverpool (GB)
- King's College London (GB)
- London School of Hygiene & Tropical Medicine (GB)
Publication Details
- Journal
- Public Health in Practice
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1016/j.puhip.2025.100717
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- UK Research and Innovation
- Department of Health and Social Care